SUPERNUS PHARMACEUTICALS, INC. — Earnings Release 2012

*UNITED STATES SECURITIES AND EXCHANGE COMMISSION*

*Washington, D.C. 20549*

*FORM 8-K*

*CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934*

Date of Report (Date of earliest event reported): June 7, 2012

*Supernus Pharmaceuticals, Inc.*

(Exact name of registrant as specified in its charter)

Registrant’s telephone number, including area code: (301) 838-2500

*Not Applicable*

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SEQ.=1,FOLIO='',FILE='C:\JMS\106757\12-14277-1\task5388282\14277-1-ba.htm',USER='106757',CD='Jun 7 12:30 2012'

*Item 2.02 Results of Operations and Financial Condition*

On June 7, 2012 Supernus Pharmaceuticals, Inc. (the “Company”) issued a press release describing the Company’s financial results for the quarter ended March 31, 2012. A copy of this press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

*Item 9.01 Financial Statements and Exhibits*

(d) Exhibits

The following document is furnished as an Exhibit pursuant to Item 2.02 hereof:

Exhibit 99.1 — Press Release dated June 7, 2012 of the Company regarding financial performance for the quarter ended March 31, 2012.

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\106757\12-14277-1\task5388282\14277-1-ba.htm',USER='106757',CD='Jun 7 12:30 2012'

*SIGNATURES*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\106757\12-14277-1\task5388282\14277-1-ba.htm',USER='106757',CD='Jun 7 12:30 2012'

*EXHIBIT INDEX*

4

SEQ.=1,FOLIO='4',FILE='C:\JMS\106757\12-14277-1\task5388282\14277-1-ba.htm',USER='106757',CD='Jun 7 12:30 2012'